PATENT CLAIM ANALYSIS

Application Number: 15945887
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-09
Patent Classification: ["424", "134100"]

Abstract:
Disclosed are tumor necrosis factor receptor 1B (TNFR-1B) signaling targets and TNFR-1B mutants and their uses for treatment of diseases and disorders.

Claim (Index 15):
The method of  claim 14 , wherein the modified TNFR-1B compound or mutant recognizes TNF-alpha, but not one or more of ICOS-L, MadCAM-1 and ISLR2.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 91.0
- Lexical Diversity: 1.13636
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14003756', '14849963', '14122611', '14211604', '13761864']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6555143474298887
- 35 USC 102 Novelty (BERT): 0.5407324160710824
- Combined Prediction Score: 0.6440361542940081
- Mean Citation Score: 311.067136
- Max Citation Score: 355.4463
- Similarity Product: 199.2616006756783

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test